Research and Clinical Trials

A study led by Mayo Clinic researchers Zhi Zhang Yang, M.D., and Stephen M. Ansell, M.D., Ph.D., has found that healthy white blood cells called[...]

Research led by Mayo Clinic oncologists Roberto A. Leon Ferre, M.D., and Charles L. Loprinzi, M.D., has found that the drug oxybutynin helps reduce the[...]

As I write this message, the snow has finally stopped in Minnesota and the month of May is upon us — a time each year[...]

Mayo Clinic researchers have found that the oral drug apixaban is safe and effective to treat blood clots in patients undergoing cancer therapy. Apixaban was[...]

A less-invasive nipple-sparing mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer[...]

Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, talks about her cellular therapy research.

Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be[...]

When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better preserved cognitive function and demonstrated[...]

Rose geranium oil may help ease the symptoms of nasal vestibulitis, according to the results of a small observational study by Mayo Clinic researchers. The[...]

Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor (CAR)-T cell therapy in treating cancer. They presented[...]